UB Paderborn / Katalog / Suche / in CDI

Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen

Clinical cancer research, 2007-01, Vol.13 (1), p.228-233

2007

Link zum Volltext

Verfügbarkeit prüfen

Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases

Journal of magnetic resonance imaging, 2009-05, Vol.29 (5), p.1154-1162

2009

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy

Annals of surgical oncology, 2006-11, Vol.13 (11), p.1443-1449

2006

Link zum Volltext

Verfügbarkeit prüfen

Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases

Journal of oncology pharmacy practice, 2014-04, Vol.20 (2), p.120-129

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b trial of cabozantinib in combination with atezolizumab in patients with locally advanced or metastatic urothelial carcinoma (UC) or renal cell carcinoma (RCC)

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.TPS42-TPS42

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b trial of cabozantinib in combination with atezolizumab in patients with locally advanced or metastatic urothelial carcinoma (UC) or renal cell carcinoma (RCC)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.TPS541-TPS541

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS5090-TPS5090

2017

Link zum Volltext

Verfügbarkeit prüfen

Retrospective analysis of toxicity in patients (pts) with liver metastases (mets) from phase 3 studies of trastuzumab emtansine (T-DM1) in pts with metastatic breast cancer (MBC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.609-609

2014

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy for breast cancer

Langenbeck's archives of surgery, 2002-07, Vol.387 (3-4), p.109-116

2002

Link zum Volltext

Verfügbarkeit prüfen

Racial/ethnic (RE) differences in the occurrence of HER2 and hormone receptor (HR)-defined breast cancer (BC) in California (CA)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.634-634

2014

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy

Breast disease, 2004, Vol.21, p.23

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of adjuvant trastuzumab on outcomes of HER2-positive breast cancer patients treated with HER2-targeted therapy in the metastatic setting

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.527-527

2012

Link zum Volltext

Verfügbarkeit prüfen

Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy prior to surgery define outcome

Surgery, 2012-01, Vol.151 (5), p.710-716

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of exemestane in combination with metformin and rosiglitazone in non-diabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer

Cancer chemotherapy and pharmacology, 2012-09, Vol.71 (1), p.63-72

2012

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy

Textbook of Bone Metastases, 2005, p.259-275

2005

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for Breast Cancer

Breast Cancer 2nd edition, p.345-385

Link zum Volltext

Verfügbarkeit prüfen

Medical Therapy of Locally Advanced Breast Cancer

Breast Cancer Management and Molecular Medicine, 2007, p.427-447

2007

Link zum Volltext

Verfügbarkeit prüfen

The Oslo definitions for coeliac disease and related terms

Gut, 2013-01, Vol.62 (1), p.43-52

2013

Link zum Volltext

Verfügbarkeit prüfen

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Journal of the American College of Cardiology, 2017-10, Vol.70 (16), p.2048-2090

2017

Link zum Volltext

Verfügbarkeit prüfen

Outcome measures in coeliac disease trials: the Tampere recommendations

Gut, 2018-08, Vol.67 (8), p.1410

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma

Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases

Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy

Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases

Phase 1b trial of cabozantinib in combination with atezolizumab in patients with locally advanced or metastatic urothelial carcinoma (UC) or renal cell carcinoma (RCC)

Phase 1b trial of cabozantinib in combination with atezolizumab in patients with locally advanced or metastatic urothelial carcinoma (UC) or renal cell carcinoma (RCC)

A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)

Retrospective analysis of toxicity in patients (pts) with liver metastases (mets) from phase 3 studies of trastuzumab emtansine (T-DM1) in pts with metastatic breast cancer (MBC)

Atezolizumab (atezo) vs. chemotherapy (chemo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Immune biomarkers, tumor mutational burden (TMB), and clinical outcomes from the phase III IMvigor211 study

Adjuvant chemotherapy for breast cancer

Racial/ethnic (RE) differences in the occurrence of HER2 and hormone receptor (HR)-defined breast cancer (BC) in California (CA)

Neoadjuvant chemotherapy

Impact of adjuvant trastuzumab on outcomes of HER2-positive breast cancer patients treated with HER2-targeted therapy in the metastatic setting

Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy prior to surgery define outcome

Phase I trial of exemestane in combination with metformin and rosiglitazone in non-diabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer

Chemotherapy

Chemotherapy for Breast Cancer

Medical Therapy of Locally Advanced Breast Cancer

The Oslo definitions for coeliac disease and related terms

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology

Outcome measures in coeliac disease trials: the Tampere recommendations

Aktive Filter

Suchergebnisse filtern